Faster access than browser!
8 relations: Amyotrophic lateral sclerosis, Glucuronide, Intravenous therapy, Japan, Mitsubishi Tanabe Pharma, Stroke, Stroke recovery, The New York Times.
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), and Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles.
New!!: Edaravone and Amyotrophic lateral sclerosis · See more »
Glucuronide
A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond.
New!!: Edaravone and Glucuronide · See more »
Intravenous therapy
Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).
New!!: Edaravone and Intravenous therapy · See more »
Japan
Japan (日本; Nippon or Nihon; formally 日本国 or Nihon-koku, lit. "State of Japan") is a sovereign island country in East Asia.
New!!: Edaravone and Japan · See more »
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceuticals company, a subsidiary of Mitsubishi Chemical Holdings Corporation.
New!!: Edaravone and Mitsubishi Tanabe Pharma · See more »
Stroke
A stroke is a medical condition in which poor blood flow to the brain results in cell death.
New!!: Edaravone and Stroke · See more »
Stroke recovery
The primary goals of stroke management are to reduce brain injury and promote maximum patient recovery.
New!!: Edaravone and Stroke recovery · See more »
The New York Times
The New York Times (sometimes abbreviated as The NYT or The Times) is an American newspaper based in New York City with worldwide influence and readership.
New!!: Edaravone and The New York Times · See more »
Redirects here:
C10H10N2O, Norantipyrine, Radicava, Radicut.
